Accedi a banche dati online | Convegnodetail
Anteprima di stampa
 
 

Gene Therapy for Muscular Disorders

Evvnt Promotion / evvnt
-
25.05.2021 - 27.05.2021  Online
Time: 08:00 to 17:00
 
Temi della conferenza
With clinical holds lifting there has been more investment and clinical progress in the gene therapy for muscular disorders space than ever before, yet the consequences of toxicity are not a distant memory. Despite the successes, there are still withstanding challenges for gene therapy developers targeting the muscle when it comes to optimizing delivery and navigating toxicity to develop truly safe and transformative therapeutics for muscular disorders patients.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/727634-0?pid=4832

Speakers: Michael O'Callaghan, Senior Vice President, Translational Medicine, AskBio, Michael Roberts, Chief Technology Officer, AskBio Europe, and more.
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/727634-1?pid=4832
Mr. Ellie Saunders
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
USD 1199.00 to USD 2696.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Helix - Forschung & Beratung WienÖsterreichische Akademie der ÄrzteCharité International AcademyAMREF - African Medical and Research FoundationAlumni Club Medizinische Universität WienEuropean Public Health Association (EUPHA)newTreeSwiss Tropical and Public Health Institute